645 related articles for article (PubMed ID: 17469849)
1. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
2. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
Castiglione F; Lazzarini A; Carrano L; Corti E; Ciciliato I; Gastaldo L; Candiani P; Losi D; Marinelli F; Selva E; Parenti F
Chem Biol; 2008 Jan; 15(1):22-31. PubMed ID: 18215770
[TBL] [Abstract][Full Text] [Related]
3. Structure revision of the lantibiotic 97518.
Maffioli SI; Potenza D; Vasile F; De Matteo M; Sosio M; Marsiglia B; Rizzo V; Scolastico C; Donadio S
J Nat Prod; 2009 Apr; 72(4):605-7. PubMed ID: 19301921
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.
Simone M; Monciardini P; Gaspari E; Donadio S; Maffioli SI
J Antibiot (Tokyo); 2013 Feb; 66(2):73-8. PubMed ID: 23168402
[TBL] [Abstract][Full Text] [Related]
5. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
6. The antibiotic planosporicin coordinates its own production in the actinomycete Planomonospora alba.
Sherwood EJ; Bibb MJ
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2500-9. PubMed ID: 23776227
[TBL] [Abstract][Full Text] [Related]
7. A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.
Carrano L; Abbondi M; Turconi P; Candiani G; Marinelli F
Biomed Res Int; 2015; 2015():419383. PubMed ID: 26346738
[TBL] [Abstract][Full Text] [Related]
8. Cloning and analysis of the planosporicin lantibiotic biosynthetic gene cluster of Planomonospora alba.
Sherwood EJ; Hesketh AR; Bibb MJ
J Bacteriol; 2013 May; 195(10):2309-21. PubMed ID: 23475977
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the isolation and characterization of antibacterial lantibiotics.
Jabes D; Donadio S
Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
[TBL] [Abstract][Full Text] [Related]
11. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
[TBL] [Abstract][Full Text] [Related]
12. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.
Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC
Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283
[TBL] [Abstract][Full Text] [Related]
14. Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.
Maffioli SI; Monciardini P; Catacchio B; Mazzetti C; Münch D; Brunati C; Sahl HG; Donadio S
ACS Chem Biol; 2015 Apr; 10(4):1034-42. PubMed ID: 25574687
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
16. Generation of an actagardine A variant library through saturation mutagenesis.
Boakes S; Ayala T; Herman M; Appleyard AN; Dawson MJ; Cortés J
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1509-17. PubMed ID: 22526797
[TBL] [Abstract][Full Text] [Related]
17. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
[TBL] [Abstract][Full Text] [Related]
18. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.
Shenkarev ZO; Finkina EI; Nurmukhamedova EK; Balandin SV; Mineev KS; Nadezhdin KD; Yakimenko ZA; Tagaev AA; Temirov YV; Arseniev AS; Ovchinnikova TV
Biochemistry; 2010 Aug; 49(30):6462-72. PubMed ID: 20578714
[TBL] [Abstract][Full Text] [Related]
19. The genetics of lantibiotic biosynthesis.
Jack R; Bierbaum G; Heidrich C; Sahl HG
Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
Lawton EM; Cotter PD; Hill C; Ross RP
FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
